Monday, October 21, 2019 12:35:14 PM
In these States, deals were supposedly on the table and not agreed to by whomever. Let’s assume they were unfavorable to BIEL. Would we have generated more interest, $$, partnerships among the competitors of the company that we signed that first mediocre deal with? Would that signing lead us to future good deals and growth as others compete for the right to partner/license our products given the door has been cracked open by BIEL with that first signing? What is that worth?
The "danger" is that since we have not capitalized on current approvals here or elsewhere for whatever reason, given that we have a clearly disruptive technology, given that the PPS is ridiculously low, given that full clearance may come through at any time, and given the uncertainty regarding a CEO and Board, I believe we are at risk of a buyout. Not what I wish for right now as that buyout would not be from a much higher PPS we should be at given the clearances we already have.
Instead of the Ferrari some want, they might left with a very expensive new bicycle for all the years of support and waiting. Yes, it's always a risk.
What is the company worth? What are shareholders worth? Are they one and the same?
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM